Project Grant K02AG095384
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to equip the candidate with skills to establish an independent research program focused on identifying modifiable lifestyle factors, such as physical activity and sleep, that can enhance cognitive resilience in aging and Alzheimer's disease-related dementias (ADRDs). The $129,659 award, with a project period from June 15, 2025 to March 31, 2030, will support a longitudinal study to assess whether...
- This federal Project Grant award of $125,000.00, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports research to investigate the relationship between sleep loss and neurodegeneration. The grantee, The Washington University, will use the funding to examine how sleep deprivation can epigenetically alter microglial responses to tau protein aggregates, which is a key pathological feature of Alzheimer's disease and other tauopathies. The research aims to identify...
- This $612,005 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to characterize sleep slow-wave activity (SWA) and its relationship to chronic stress, accelerated aging, and Alzheimer's disease in a cohort of 200 Black older adults aged 55-80 in the United States. The award will support ambulatory overnight sleep monitoring, biomarker assessments, and cognitive testing to examine how chronic stress impacts SWA and its association with markers of...
- The National Institute on Aging (NIA) awarded a $780,466 Project Grant (CFDA 93.866 Aging Research) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, with a period of performance from December 15, 2024 to November 30, 2029. The goal of this project is to develop digital biomarkers using single-channel sleep electroencephalography (EEG) to monitor brain health and detect pathological aging and early neurodegenerative changes, such as those seen...
- This federal Project Grant award for $366,648.00 was provided by the National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), to New York University (NYU). The funding supports the development of statistical methods for improving estimation and prediction models related to Alzheimer's disease (AD) progression, leveraging data from longitudinal cohort studies. Specifically, the project aims to address challenges posed by complex truncation and censoring...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is focused on assessing whether genetic risk variants for Alzheimer's disease (AD) have a pleiotropic effect on sleep. The primary objectives are to conduct in silico variant-to-gene mapping analysis to identify potential shared genetic factors underlying AD and sleep phenotypes, and to use CRISPR in zebrafish models to directly evaluate the impact of putative AD...
- The National Institute on Aging (NIA), through the Aging Research Federal Grant Program (CFDA 93.866), awarded a $758,049 Project Grant to the University of Wisconsin-Madison to establish the Lucidity in Alzheimer's and Dementia (LEAD) Network. This interdisciplinary research infrastructure will facilitate collaborations and advance measurement science on lucid episodes (LE) - transient recoveries of function observed in some individuals with advanced Alzheimer's disease and related dementias....
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $366,985 to the University of South Florida (USF) to develop the USF Health Expanding Research in AD/ADRD (ERA) Post-Baccalaureate Research Education Program (PREP). The program aims to train a cohort of post-baccalaureate students with limited research experience to transition into Alzheimer's disease and related dementias (AD/ADRD) research-focused doctoral programs. Led by Professors Paula C....
- This federal Project Grant award of $442,938, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports research at the University of California, San Francisco (UCSF) to investigate the relationship between sleep, memory, and aging. The key objectives are to: 1) characterize how aging affects sleep patterns required for memory consolidation and synaptic plasticity during long-term memory formation; and 2) determine how upregulating the unfolded protein response can...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $149,148 to the University of Florida to support the project "LEADERSHIP TRAINING IN REAL-WORLD DATA ANALYTICS: SLEEP AND ALZHEIMER'S DISEASE." The goal is to develop the recipient's skills in leading multidisciplinary research teams to generate insights from real-world data and translate them into population health improvements, with a focus on understanding the impact of sleep apnea treatment on cognitive decline and Alzheimer's disease. The 5-year award, starting on Sep 9, 2025, will enable the recipient to obtain training in real-world data methodologies, gain leadership skills for managing interdisciplinary collaborations, and establish a sleep research collaboratory at the University of Florida leveraging its extensive healthcare data resources.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $149.1k | 9/9/25 |